2nd Quarter 2007

Covance Out In Front

Publications

Globe D, Glidden D, Hertel J, Thomas J, Ackerman M, Chidolue F, Blanco B, Borden A, Goss T, Xu X, Kewalramani R. Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with chronic kidney disease and their families.
Nephrology Nursing Journal 2007;34(2):151-161.

Lotery A, Xu X, Zlateva G, Loftus J. Burden of illness, visual impairment, and health resource utilisation of patients with neovascular age-related macular degeneration: Results from the United Kingdom cohort of a five-country cross-sectional study.
British Journal of Ophthalmology 2007 May 15; (Epub ahead of print)

Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J, Goss T. Burden and resource utilization of neovascular AMD: Findings of a multicountry study.
Archives of Ophthalmology. (Accepted for publication)

Watrous R, Thompson W, Ackerman S. The impact of computer-assisted auscultation on physician referrals of asymptomatic patients with heart murmurs.
Clinical Cardiology 2007. (Accepted for publication)

Abstract Presentations

Anastassopoulos K, O'Byrne K, Maxon M, Schaefer C. Medical resource utilization (MRU) and costs associated with XYOTAX(tm) (paclitaxel poliglumex; PPX) compared to gemcitabine (Gem) or vinorelbine (Vin) in non-small cell lung cancer (NSCLC) patients. Presented at the American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 1-5, 2007.

Skidmore G, Ackerman S, Bergin C, Ross D, Butler J, Rittenberg J, Suthar M. Cost-effectiveness of interspinous process decompression for lumbar spinal stenosis: a comparison with conservative care and laminectomy. Accepted for presentation at the North American Spine Society (NASS) 22nd Annual Meeting, Austin, TX, October 23-27, 2007.

Weber P, Wirostko B, Shah S, Xu X, Zlateva G, Barkume C. Treatment of newly diagnosed neovascular age-related macular degeneration (NV-AMD) with pegaptanib sodium monotherapy in U.S. community-based practices. Presented at the 7th European Society of Retina Specialists (EURETINA) Congress, Monte Carlo, Monaco, May 17-20, 2007.

Conference Presentations

Edgar Adams, Sc.D., presented "RiskMAP Plans: Enhance Patient Safety While Mitigating Product Liability Risk" at the BIO International Convention, Boston, MA, May 6-9, 2007.

Edgar H. Adams, Sc.D., and Jeffrey J. Stoddard, M.D., attended the Food and Drug Administration's (FDA) public hearing on the use of medication guides to communicate drug risk information to patients, Washington, D.C., June 12-13, 2007. http://www.fda.gov/cder/meeting/medication_guides_200706.htm

Jeffrey Stoddard, M.D., presented "Risk Management for Vaccine Products" at the Drug Information Association's (DIA) 43rd Annual Meeting, Atlanta, GA, June 17-21, 2007.

Luis Gutierrez presented a statement at the Agency for Healthcare Research and Quality's (AHRQ) and the Food and Drug Administration's (FDA) Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges public workshop, Rockville, MD, June 25-26, 2007. http://www.fda.gov/cder/meeting/riskMAPs.htm

Caroline Schaefer will present "Demonstrating Product Value to Support Pricing and Reimbursement" at Exl Pharma's Drug Pricing and Reimbursement Seminar, Morristown, NJ, July 16-17, 2007.

Helene Kennedy will present "Building Adherence by Bridging the Payment Gap for the Growing Underinsured Population" at IIR's THE Pharmaceutical Marketing Event, Philadelphia, PA, September 19-21, 2007.

Sean Kennedy will present "Sequential Adaptive Considerations in Registry Application Selection" at CBI's Registries and Post-Approval Studies Congress, Philadelphia, PA, September 27-28, 2007.

John Carlsen will present "Part B vs. Part D — Current Issues and Future Implications that Impact Formulary and Reimbursement Strategies" at CBI's Formulary and Reimbursement Strategies for Effective Product Planning conference, King of Prussia, PA, September 27-28, 2007.